The Efficacy of Systemic Valacyclovir (Valtrex) on Periodontitis
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The experiment outlined in this proposal is designed to test the hypothesis that herpesvirus
suppression by the systemic anti-herpesvirus valacyclovir (Valtrex) can significantly help to
arrest the progressive course of severe marginal periodontitis in adult patients. A
prospective, randomized, placebo-controlled, double-blind, clinical trial is employed to test
this hypothesis.